繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Glucose Health宣布领导层变动

2025-09-27 04:18

  • Glucose Health (OTCPK:GLUC) on Friday announced that its Chief Executive Officer and Chief Financial Officer has resigned, effective September 30, 2025, for personal reasons. 
  • Murray Fleming, the company’s sole Director, will perform the functions of CEO and CFO on an interim basis to maintain administrative continuity and assist in finding permanent replacements.
  • This arrangement will remain until successors are appointed, the company winds down operations, or the board decides on further action.
  • There were no disagreements with the company on any matter relating to its operations, policies, or practices.
  • The company confirms that day-to-day operations will continue under the Director’s oversight; however, the company has limited operating capital and uncertain prospects to continue as a going concern.
  • Source: Press Release

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。